Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.

Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, Schildkraut JM, Parmigiani G, Clark S, Lobach DF, Bastian LA.

J Gen Intern Med. 2005 Apr;20(4):360-5.

2.

Patients' interest in discussing cancer risk and risk management with primary care physicians.

Buchanan AH, Skinner CS, Rawl SM, Moser BK, Champion VL, Scott LL, Strigo TS, Bastian L.

Patient Educ Couns. 2005 Apr;57(1):77-87.

PMID:
15797155
3.

Recommendation recall and satisfaction after attending breast/ovarian cancer risk counseling.

Bober SL, Hoke LA, Duda RB, Tung NM.

J Genet Couns. 2007 Dec;16(6):755-62.

PMID:
17674165
4.

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.

Bober SL, Hoke LA, Duda RB, Regan MM, Tung NM.

J Clin Oncol. 2004 Dec 15;22(24):4951-7.

PMID:
15598980
5.
6.

Guidelines for evaluation of patients at risk for inherited breast and ovarian cancer: recommendations of the Department of Defense Familial Breast/Ovarian Cancer Research Project.

Fries MH, Holt C, Carpenter I, Carter CL, Daniels J, Flanagan J, Murphy K, Hailey BJ, Martin L, Hume R, Hudson G, Cadman M, Weatherly R, Nunes ME.

Mil Med. 2002 Feb;167(2):93-8.

PMID:
11873549
7.

Simultaneous interdisciplinary counseling in German breast/ovarian cancer families: first experiences with patient perceptions, surveillance behavior and acceptance of genetic testing.

Hofferbert S, Worringen U, Backe J, Rückert EM, White K, Faller H, Grimm T, Caffier H, Chang-Claude J, Weber BH.

Genet Couns. 2000;11(2):127-46.

PMID:
10893664
8.

Physician counseling for colorectal cancer screening: impact on patient attitudes, beliefs, and behavior.

Fenton JJ, Jerant AF, von Friederichs-Fitzwater MM, Tancredi DJ, Franks P.

J Am Board Fam Med. 2011 Nov-Dec;24(6):673-81. doi: 10.3122/jabfm.2011.06.110001.

9.

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.

Morgan D, Sylvester H, Lucas FL, Miesfeldt S.

Fam Cancer. 2009;8(4):277-87. doi: 10.1007/s10689-009-9242-z.

PMID:
19347608
10.

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.

11.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62.

12.
13.

Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.

Rondanina G, Puntoni M, Severi G, Varricchio C, Zunino A, Feroce I, Bonanni B, Decensi A.

J Clin Oncol. 2008 Mar 20;26(9):1537-43. doi: 10.1200/JCO.2007.13.6739.

PMID:
18349406
14.

Acceptance of tamoxifen chemoprevention by physicians and women at risk.

McKay A, Latosinsky S, Martin W.

Cancer. 2005 Jan 1;103(1):209-10. No abstract available.

15.

Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer.

Calzone KA, Prindiville SA, Jourkiv O, Jenkins J, DeCarvalho M, Wallerstedt DB, Liewehr DJ, Steinberg SM, Soballe PW, Lipkowitz S, Klein P, Kirsch IR.

J Clin Oncol. 2005 May 20;23(15):3455-64.

PMID:
15908654
16.

Hereditary breast and ovarian cancer: what the primary care physician should know.

Khoury-Collado F, Bombard AT.

Obstet Gynecol Surv. 2004 Jul;59(7):537-42. Review.

PMID:
15199272
18.

Results of a randomized study of telephone versus in-person breast cancer risk counseling.

Helmes AW, Culver JO, Bowen DJ.

Patient Educ Couns. 2006 Dec;64(1-3):96-103.

PMID:
16427245
19.

Genetic counseling for BRCA1/2: a randomized controlled trial of two strategies to facilitate the education and counseling process.

Wang C, Gonzalez R, Milliron KJ, Strecher VJ, Merajver SD.

Am J Med Genet A. 2005 Apr 1;134A(1):66-73.

PMID:
15690408
20.

Physicians' assessments of adjuvant tamoxifen's effectiveness in older patients with primary breast cancer.

Lash TL, Gurwitz JH, Silliman RA.

J Am Geriatr Soc. 2005 Nov;53(11):1889-96.

PMID:
16274369
Items per page

Supplemental Content

Support Center